A New Facet of NDRG1 in Pancreatic Ductal Adenocarcinoma: Suppression of Glycolytic Metabolism.
Wensheng Liu,Bo Zhang,Qiangsheng Hu,Yi Qin,Wenyan Xu,Si Shi,Chen Liang,Qingcai Meng,Jinfeng Xiang,Dingkong Liang,Shunrong Ji,Jiang Liu,Pengfei Hu,Liang Liu,Chen Liu,Jiang Long,Quanxing Ni,Xianjun Yu,Jin Xu
DOI: https://doi.org/10.3892/ijo.2017.3938
2017-01-01
International Journal of Oncology
Abstract:N-myc downstream-regulated gene 1 (NDRG1) is known as tumor/metastasis suppressor in a variety of cancers including pancreas, being involved in angiogenesis, cancer growth and metastasis. However, the precise molecular mechanism how NDRG1 exerts its inhibitory function in pancreatic cancer remains unclear. In this investigation, we demonstrated that K-Ras plays a vital role in modulating NDRG1 protein level in PDAC cancer cells in vitro, which is mediated through ERK signaling. Noteworthy, K-Ras downstream Akt/mTOR signaling is inhibited upon NDRG1 overexpression, resulting in decease of HIF1α level. Moreover, NDRG1 has a unique role in modulating cancer metabolism of pancreatic ductal adenocarcinoma (PDAC). The mechanism accounting for NDRG1 in modulating aerobic glycolysis, at least partly, relied on its regulation of glycolysis genes including GLUT1, HK2, LDHA and PDK1. Additionally, NDRG1 is shown to suppress the activity of HIF1α, which is responsible for regulation of glycolysis enzymes. The current study is the first to elucidate a unique facet of the potent tumor/metastasis suppressor NDRG1 in the regulation of PDAC glycolysis, leading to important insights into the mechanism by which NDRG1 exert inhibitory function in PDAC.